Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Frova frovatriptan regulatory update

The partners said FDA has a new PDUFA date of Sept. 30 for an sNDA for 2.4

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE